11 Mood disorders and related drugs Flashcards
Depression dagnosis and treatment ratios
50% undagnosed
25% untreated
25% Treated
60- 80% improve if treated
Mood disorder epidemiology etc
- 4th in disability adjusted life years
- same cost as heart disease
- Low recognition rate
- Highly treatable
- 5% prevalence for dysthymic disorder and MDD
- functional impairment exceeds: DM, HTN, Arthritis, Back problems, GI
Depression presentation
Multiple Somatic complaints Anxiety "nerves, headaches" mex "Weakness, imbalance"chinese "heartbroken" hopi
Symptom and psychiatric rates
Greater number of symptoms associated with prevalance of psychiatric disorders.
Major depressive episode
5 symptoms at least two weeks with depressed moos or ahedonia
Depression criteria
- 2 weeks or more
- SIGECAPS 5 of 9
- clinically significant distress
- Not substance or medical condition
- not bereavement
PH9 scoring
several days-1pt
More than 1/2 - 2pt
Every day - 3pt
5-9 stable
10-14dysthymia or mild depression TX?
15-19 MDD TX
>20 SEVERE MDD- TX meds and psychotherapy
Suicide red flags
ISPATHWARM
ideation substance abuse purposeless anxiety trapped hopelessness Withdrawl anger recklessness mood swings
Bereavement stages
Stage 1: shock
*numbness, unreality - crying abdominal pang/empptiness, sighing, tightness in throat- thoughts of denial or disbelief
Stage 2: Preocupation
*guilt, anger, sadness- weakness, anorexia, insomnia, fatigue- dreams and thoughts of deceased- ahedonia and introversion
Stage 3:Resolution
*Thinks of past with pleasure- regains interest, new relationships formed
TCAs
Imipramine, Amitryptyline, Desipramine, Nortryptyline, Doxepin, Clomipramine, Maprotilene, Amoxapine, protriptyline, trimipramine
SSRIs
Fluoxetine, sertraline, paroxetine, citalopram, fluvoxamine, escitalopram
SSRI SE
HA/dizziness N,D,Constipation Somnolence/insomnia Sweating/tremor/dry mouth Anxiety/restlessness Sexual drive
Atypical antidepressants
Buproprion, trazodone, nefazodone, venlaflaxine, mirtazapine, duloxetine, alprazolam
MAOi
Phenelzine Isocarboxazid Tranylcypramine selegiline RIMA
Additional treatments
Lithium Psychotherapy ECT Vagal nerve stimulation Transcranial Magnetic stim Deep brain stim *St john's wort, Sam-E, Reboxetine
Depression outcomes
Response Remission Relapse Recovery Recurrence
Bipolar general info
2.6% 1 year prevalence
1% lifetime prevalence
4.4% lifetime rate in us
15% suicide rateq
Manic episode
*Distinct period >1 week
*Elevated or expansive mood (abnormal and persistent)
*Irritable mood
*Severe
Traits:
*Grandiosity
*Decreased need for sleep
*Hyperverbal/pressured speech
*Flight of ideas
*distractability
*Psychomotor agitation and goal seeking actvity
*Pleasurable activity with painful consequences